Mastospheres as a new 3D ex vivo breast cancer microtumors for preclinical drug testing

被引：0
|
作者：
Richon, Sophie [1 ]
Cottu, Paul [2 ]
Weiswald, Louis-Bastien [2 ]
Guinebretiere, Jean-Marc [2 ]
Marangoni, Elisabetta [2 ]
Assayag, Franck [2 ]
Thuleau, Aurelie [2 ]
Labiod, Dalila [2 ]
Decaudin, Didier [2 ]
Bellet, Dominique [2 ]
Dangles-Marie, Virginie [2 ]
机构：
[1] Fac Pharm Paris Descartes, Paris, France
[2] Inst Curie, Paris, France
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-LB-111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-111
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy
    Dhar, Sumeer
    Chiovaro, Francesca
    Tanos, Tamara
    Hejhal, Tomas
    Heilemariam, Seife
    Kelm, Jens
    Irmisch, Anja
    Levesque, Mitchell
    [J]. CANCER RESEARCH, 2017, 77
  • [2] 3D EX VIVO PATIENT TISSUE PLATFORM FOR IMMUNOONCOLOGY DRUG TESTING
    Basten, Sander
    Beztsinna, Nataliia
    Grillet, Fanny
    Yan, Kuan
    Meesters, Niels
    van der Meer, Donny
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A212 - A212
  • [3] Perfused 3D tri-culture breast cancer microtumors for accurate prediction of drug response
    DesRochers, Tessa M.
    Shuford, Stephen
    Mattingly, Christina
    Bruce, Terri
    Liu, Zhiyi
    Quinn, Kyle
    Georgakoudi, Irene
    Kaplan, David L.
    Orr, David
    Crosswell, Howland E.
    [J]. CANCER RESEARCH, 2015, 75
  • [4] Multivariate analysis of ex vivo kidney 3D immune-microtumors for functional precision medicine
    Peerani, Eleonora
    Nan, Keqian
    Wiskerke, Demi A.
    Richardson, Thomas D.
    Maximchick, Polina
    Kearney, Jay
    de Fraine, George R.
    Loughrey, Kerrie L.
    Ient, Jonathan
    Hudson, Jessica A.
    Kaffa, Andreas
    Crawley, Aston M.
    Bah, Nourdine K.
    Molina, Edgar G. Lopez
    Tham, Elli
    Iori, Francesco
    Williams, Matthew H.
    Tran, Maxine G.
    Ranatunga, Duleek N.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [5] PRECLINICAL DRUG TESTING IN EX VIVO 3-D DYNAMIC CULTURE IN ERDHEIM-CHESTER DISEASE
    Biavasco, R.
    Belloni, D.
    Doglioni, C.
    Dagna, L.
    Ferrero, E.
    Ferrarini, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 370 - 371
  • [6] Optimization of an Ex-Vivo Preclinical Model for Drug Testing
    Marin, E.
    Duch, P.
    Gabasa, M.
    Urrea, E.
    Ikemori, R.
    Diaz-Valdivia, N.
    Teixido, C.
    Reguart, N.
    Alcaraz, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S689 - S689
  • [7] Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies
    Monteiro, Maria V.
    Gaspar, Vitor M.
    Mendes, Luis
    Duarte, Iola F.
    Mano, Joao F.
    [J]. SMALL METHODS, 2021, 5 (05)
  • [8] Pancreatic cancer 3D organoids: a co-clinical platform for translational research and ex vivo drug testing
    Hussung, S.
    Koehler, K.
    Koehne, N.
    Michalczyk, S.
    Mastroianni, J.
    Fritsch, K.
    Zeiser, R.
    Boerries, M.
    Wittel, U.
    Fritsch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 237 - 237
  • [9] Cancer 3D Models for Metallodrug Preclinical Testing
    Engracia, Diogo M. M.
    Pinto, Catarina I. G.
    Mendes, Filipa
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [10] Ex vivo 3D drug response profiling of XPDX-derived tumor cells for acceleration of preclinical drug development
    Carlson, Aaron L.
    Elrod, Ashley K.
    Williams, Natalie A.
    Moriarty, Alyssa D.
    Wick, Michael J.
    DesRochers, Teresa M.
    [J]. CANCER RESEARCH, 2022, 82 (12)
12345